The biotechnology R&D intensity in Japan's business sector is forecasted to rise steadily from 0.089% in 2024 to 0.14% in 2028. Over the next four years, each year-on-year increase demonstrates a positive growth trend, signaling a significant shift towards more considerable investment in biotechnology research and development. Specifically, the year-on-year variations from 2024 to 2028 highlight these upward movements.
Comparing the data from 2026 and 2024, we observe a consistent upward trajectory with impressive growth rates. The greatest growth occurs between 2027 and 2028. Summarizing the CAGR (Compound Annual Growth Rate) over five years indicates steady and robust annual growth.
Future trends to watch for include potential technological breakthroughs that could further accelerate R&D intensity, shifts in government policy and funding affecting industry investments, and increased collaborations between Japanese firms and international biotech companies. Monitoring these factors will be crucial for anticipating changes in market dynamics and R&D focus.
